Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic study of KW-6485P (topiramate) in pediatric epilepsy
jRCT2080220854Phase 2
- Sponsor
- Kyowa Kirin
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of topiramate in epilepsy and focal-onset epileptic seizures, sponsored by Kyowa Kirin. Primary endpoint: Pharmacokinetic profile of topiramate (KW-6485P).
02
Drugs
topiramate
03
Conditions
epilepsyfocal-onset epileptic seizures
Beyond the preview
Go deeper on jRCT2080220854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220854.